Metraipolis › archive › dc_a970cff6addf

The Sigma-1 Gene as a Prognostic Marker in Chemotherapy-Treated Breast Cancer-Antagonists' Synergism With Paclitaxel In Vitro — Europe PMC PMID:41223123

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41223123
DOI: 10.1002/cam4.71376
License (as archived): solo-consultazione
Archived: 2026-11-08T21:14:59.204Z
SHA-256 of the archived text: 3b778f250e56b6225c1ef2c2444cc968cd75a961a5a6667f044754e3de83c4d9
Stable URL of this page: https://metraipolis.com/documento/dc_a970cff6addf

How to cite

The Sigma-1 Gene as a Prognostic Marker in Chemotherapy-Treated Breast Cancer-Antagonists' Synergism With Paclitaxel In Vitro — Europe PMC PMID:41223123 — Europe PMC (en), https://europepmc.org/article/MED/41223123 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a970cff6addf (Metraipolis archive dc_a970cff6addf, sha256 3b778f250e56b6225c1ef2c2444cc968cd75a961a5a6667f044754e3de83c4d9)

BibTeX

@misc{dca970cff6addf,
  title = {The Sigma-1 Gene as a Prognostic Marker in Chemotherapy-Treated Breast Cancer-Antagonists' Synergism With Paclitaxel In Vitro — Europe PMC PMID:41223123},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41223123},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a970cff6addf; sha256 3b778f250e56b6225c1ef2c2444cc968cd75a961a5a6667f044754e3de83c4d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41223123. Agents can read the archived copy with the MCP tool read_document.